Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRO
2776
DELISTED
Akero Therapeutics
AKRO
| $579K | ﹤0.01% |
+20,800
| New | +$630K |
|
2777
Wintrust Financial
WTFC
$11B
| $576K | ﹤0.01% |
4,621
-64,074
| -93% | -$7.91M |
|
2778
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$142M
| $576K | ﹤0.01% |
+12,578
| New | +$608K |
|
2779
US Gold Corp
USAU
$249M
| $576K | ﹤0.01% |
93,900
+70,214
| +296% | +$465K |
|
|
TVRD
2780
Tvardi Therapeutics
TVRD
$22.1M
| $575K | ﹤0.01% |
31,343
+539
| +2% | +$5.87K |
|
2781
German American Bancorp
GABC
$1.92B
| $573K | ﹤0.01% |
14,249
-6,200
| -30% | -$263K |
|
2782
Cadiz
CDZI
$292M
| $573K | ﹤0.01% |
+110,100
| New | +$397K |
|
2783
Beam Therapeutics
BEAM
$2.74B
| $568K | ﹤0.01% |
+22,907
| New | +$585K |
|
2784
Immunic
IMUX
$217M
| $567K | ﹤0.01% |
56,662
+17,754
| +46% | +$224K |
|
2785
Value Line
VALU
$360M
| $565K | ﹤0.01% |
10,700
+200
| +2% | +$10.2K |
|
2786
Star Holdings Shares of Beneficial Interest
STHO
$117M
| $563K | ﹤0.01% |
57,892
-4,207
| -7% | -$49.1K |
|
2787
Cohen & Steers
CNS
$4.4B
| $563K | ﹤0.01% |
6,100
-600
| -9% | -$59.4K |
|
2788
a.k.a. Brands
AKA
$119M
| $563K | ﹤0.01% |
30,069
| – | – |
|
2789
Red Violet
RDVT
$1.11B
| $563K | ﹤0.01% |
15,540
+4,700
| +43% | +$157K |
|
2790
Scully Royalty
SRL
$90.9M
| $562K | ﹤0.01% |
60,714
+700
| +1% | +$5.33K |
|
2791
Alpha Teknova
TKNO
$396M
| $560K | ﹤0.01% |
67,029
-18,971
| -22% | -$132K |
|
2792
Vanguard Information Technology ETF
VGT
$151B
| $560K | ﹤0.01% |
+7,200
| New | +$553K |
|
2793
Nortech Systems
NSYS
$42.5M
| $558K | ﹤0.01% |
54,199
-2,600
| -5% | -$29.5K |
|
2794
Metagenomi Therapeutics
MGX
$46.5M
| $555K | ﹤0.01% |
153,800
-28,300
| -16% | -$68.3K |
|
2795
Century Casinos
CNTY
$34.3M
| $554K | ﹤0.01% |
170,949
+3,800
| +2% | +$13.4K |
|
|
CTEV
2796
Claritev Corp
CTEV
$599M
| $553K | ﹤0.01% |
37,415
+4,500
| +14% | +$39.7K |
|
2797
Biodesix
BDSX
$251M
| $551K | ﹤0.01% |
18,010
+15,952
| +775% | +$469K |
|
2798
PrimeEnergy Resources
PNRG
$316M
| $549K | ﹤0.01% |
2,500
| – | – |
|
2799
BioLife Solutions
BLFS
$1.72B
| $548K | ﹤0.01% |
21,100
-33,280
| -61% | -$828K |
|
2800
Franklin Financial Services
FRAF
$289M
| $547K | ﹤0.01% |
18,300
-500
| -3% | -$16K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.